Endothelial dysfunction is the initial process of
atherosclerosis.
Heat shock protein 90 (Hsp90), as a
molecular chaperone, plays a crucial role in various
cardiovascular diseases. Hsp90 function is regulated by S-nitrosylation (SNO). However, the precise role of SNO-Hsp90 in endothelial dysfunction during
atherosclerosis remains unclear. We here identified Hsp90 as a highly S-nitrosylated target in endothelial cells (ECs) by
biotin switch assay combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS). The elevation of SNO-Hsp90 was observed in atherosclerotic human and rodent aortas as well as in
oxidized LDL (
oxLDL)-treated ECs. Inhibition of
inducible nitric oxide synthase (iNOS) or transfection with Hsp90
cysteine 521 (Cys521) mutation plasmid decreased the level of SNO-Hsp90 in
oxLDL-cultured ECs. Coimmunoprecipitation and proximity
ligation assay demonstrated that SNO-Hsp90 at Cys521 suppressed the interaction between Hsp90 and activator of Hsp90
ATPase activity 1 (AHA1), but promoted the association of Hsp90 and cell division cycle 37 (CDC37). Hsp90 Cys521 mutation increased
endothelial nitric oxide synthase (eNOS) activity and inhibited
nuclear factor kappa-B (NF-κB) signaling, thereby increasing
nitric oxide (NO) bioavailability and alleviating endothelial adhesion,
inflammation and oxidative stress in
oxLDL-treated ECs. Also, administration of endothelial-specific adeno-associated viruses of Cys521-mutated Hsp90 significantly mitigated vascular oxidative stress, macrophage infiltration and
atherosclerosis lesion areas in high fat diet-fed
ApoE-/- mice. In conclusion, SNO-Hsp90 at Cys521, that serves as a conformational switch, disrupts Hsp90/AHA1 interaction but promotes recruitment of CDC37 to exacerbate
atherosclerosis.